{"title":"AIT 2023: Current innovation and future outlook.","authors":"Magdalena Zemelka-Wiacek, Marek Jutel","doi":"10.5414/ALX02379E","DOIUrl":null,"url":null,"abstract":"<p><p>Although used for over 100 years, allergen immunotherapy (AIT) is still an indispensable tool in modern allergy managemen20t due to its potential to cure allergic diseases. Its current rapid development through the application of personalized and precision medicine approaches is strongly supported by advances in mHealth, component-resolved diagnosis (CRD)-based diagnostics, validation of novel biomarkers, advanced data management, and development of novel preparations. This review summarizes the key advances in the field and shows the perspectives for further development of next-generation AIT treatments.</p>","PeriodicalId":101298,"journal":{"name":"Allergologie select","volume":"7 ","pages":"219-228"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10740148/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergologie select","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5414/ALX02379E","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Although used for over 100 years, allergen immunotherapy (AIT) is still an indispensable tool in modern allergy managemen20t due to its potential to cure allergic diseases. Its current rapid development through the application of personalized and precision medicine approaches is strongly supported by advances in mHealth, component-resolved diagnosis (CRD)-based diagnostics, validation of novel biomarkers, advanced data management, and development of novel preparations. This review summarizes the key advances in the field and shows the perspectives for further development of next-generation AIT treatments.
过敏原免疫疗法（AIT）虽然已经使用了 100 多年，但由于其治疗过敏性疾病的潜力，它仍然是现代过敏症管理中不可或缺的工具20。目前，通过应用个性化和精准医疗方法，过敏原免疫疗法得到了快速发展，这得益于移动医疗、基于成分解析诊断（CRD）的诊断方法、新型生物标记物的验证、先进的数据管理以及新型制剂的开发等方面的进步。本综述总结了该领域的主要进展，并展示了下一代 AIT 治疗方法的进一步发展前景。
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
